MX9701301A - Sistema terapeutico transdermico que contiene estradiol que comprende aditivos higrofilicos. - Google Patents
Sistema terapeutico transdermico que contiene estradiol que comprende aditivos higrofilicos.Info
- Publication number
- MX9701301A MX9701301A MX9701301A MX9701301A MX9701301A MX 9701301 A MX9701301 A MX 9701301A MX 9701301 A MX9701301 A MX 9701301A MX 9701301 A MX9701301 A MX 9701301A MX 9701301 A MX9701301 A MX 9701301A
- Authority
- MX
- Mexico
- Prior art keywords
- hydrophylic
- therapeutic system
- oestradiol
- transdermal therapeutic
- additives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invencion se refiere a un sistema terapéutico transdérmico que contiene estradiol como substancia activa y opcionalmente además substancias activas así como un aditivo hidrofílico. El sistema terapéutico tiene una estructura colocada por capas que comprende un refuerzo que es impermeable a las substancias activas y a la humedad, una capa de matriz que contiene substancia activa y, dependiendo del caso, una capa protectora separable. El sistema está caracterizado en que el aditivo hidrofílico es un componente de la matriz.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4429664A DE4429664C2 (de) | 1994-08-20 | 1994-08-20 | Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung |
DEP4429664.9 | 1994-08-20 | ||
PCT/EP1995/003202 WO1996005815A1 (de) | 1994-08-20 | 1995-08-12 | Estradiol-tts mit wasserbindenden zusätzen |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9701301A true MX9701301A (es) | 1998-05-31 |
MXPA97001301A MXPA97001301A (es) | 1998-10-23 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
DE59504233D1 (de) | 1998-12-17 |
ATE173163T1 (de) | 1998-11-15 |
DE4429664C2 (de) | 1997-09-11 |
NZ291449A (en) | 1998-09-24 |
CZ50897A3 (en) | 1997-06-11 |
ZA956926B (en) | 1996-03-25 |
SK21997A3 (en) | 1997-07-09 |
JPH10504314A (ja) | 1998-04-28 |
FI970702A0 (fi) | 1997-02-19 |
AU700119B2 (en) | 1998-12-24 |
IL114948A (en) | 2000-10-31 |
CA2197865C (en) | 2005-10-25 |
EP0776197B1 (de) | 1998-11-11 |
PL319014A1 (en) | 1997-07-21 |
ES2126308T3 (es) | 1999-03-16 |
KR970705380A (ko) | 1997-10-09 |
DK0776197T3 (da) | 1999-07-26 |
CN1073413C (zh) | 2001-10-24 |
FI118721B (fi) | 2008-02-29 |
WO1996005815A1 (de) | 1996-02-29 |
SK280299B6 (sk) | 1999-11-08 |
NO970553L (no) | 1997-02-06 |
FI970702A (fi) | 1997-02-19 |
KR100374476B1 (ko) | 2003-04-23 |
CA2197865A1 (en) | 1996-02-29 |
EP0776197A1 (de) | 1997-06-04 |
CN1155836A (zh) | 1997-07-30 |
PL180943B1 (pl) | 2001-05-31 |
DE4429664A1 (de) | 1996-02-22 |
AU3258395A (en) | 1996-03-14 |
NO970553D0 (no) | 1997-02-06 |
IL114948A0 (en) | 1995-12-08 |
HUT77093A (hu) | 1998-03-02 |
SI0776197T1 (en) | 1999-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0384266A3 (en) | Therapeutic system for the sustained and controlled transdermal or transmucosal delivery of active agents | |
DE59808922D1 (en) | Transdermales therapeutisches system | |
MY111126A (en) | Transdermal therapeutic system comprising the active substance acetylsalicylic acid. | |
WO1997004818A3 (de) | Transdermales therapeutisches system zur abgabe von wirkstoffen über die haut an den menschlichen körper | |
MY111688A (en) | Transdermal therapeutic system comprising the active substance 17-b-estradiol (anhydous) | |
SI0776197T1 (en) | Oestradiol-containing transdermal therapeutic system comprising hydrophyllic additives | |
MX9701302A (es) | Sistema terapeutico transdermico de estradiol que comprende aditivos higroscopicos. | |
GR3032219T3 (en) | Surface-stabilised pharmaceutical preparation for application on the skin | |
DE59509643D1 (de) | Transdermales therapeutisches system mit hydrolyseschutz | |
CA2197867A1 (en) | Oestradiol transdermal therapeutic system comprising hygroscopic additives | |
CA2198092A1 (en) | Transdermal therapeutic system with protection against hydrolysis |